LIfT BioSciences heralds a new era of affordable effective cancer cell therapies simply produced from iPSCs LIfT BioSciences heralds a new era of affordable effective cancer cell therapies simply produced from iPSCs LIfT announces successful production of first-in-class neutrophil based cell therapy from...

LIfT BioSciences heralds a new era of affordable effective cancer cell therapies simply produced from iPSCs LIfT BioSciences heralds a new era of affordable effective cancer cell therapies simply produced from iPSCs LIfT announces successful production of first-in-class neutrophil based cell therapy from...

Cytovia Therapeutics’ Leadership to Present at Upcoming Conferences AVENTURA, Fla. and NATICK, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc., a biopharmaceutical company empowering natural killer (NK) cells to fight cancer through stem cell...